| Old Articles: <Older 6731-6740 Newer> |
 |
The Motley Fool April 8, 2005 Brian Gorman |
Cubist in Neutral Cubist Pharmaceuticals' pipeline may be why investors are unimpressed.  |
The Motley Fool April 8, 2005 Gardner & Moore |
Six Signs of a Winner A look back at the telltale signs of Progressive Insurance's meteoric rise.  |
The Motley Fool April 8, 2005 Stephen D. Simpson |
Is This Bud for You? Anheuser-Busch gives disappointing guidance, and the stock is at a 52-week low. Is it a buy? Not necessarily.  |
The Motley Fool April 8, 2005 Stephen D. Simpson |
Alkermes' Alcohol Alchemy A new formulation of an old drug could help alcoholics and make shareholders happy.  |
The Motley Fool April 8, 2005 Tim Beyers |
Dialing for Divas Is a luxury cell phone in your future? Nokia thinks so. Perhaps Nokia stock should be in your future, too.  |
The Motley Fool April 8, 2005 Rick Aristotle Munarriz |
Swinging for the Fences Investors don't have to play it safe in the batter's box. Why not go deep? In fact, if you're willing to accept the risks that come with aggressive investing, it may be the only way to play the game.  |
The Motley Fool April 8, 2005 Charly Travers |
The FDA Hammers Pfizer Regulatory agency orders a billion dollar blockbuster off the market. Should investors care?  |
The Motley Fool April 8, 2005 Rich Smith |
BJ's: Wholesaler or Weatherman? The company combined its monthly sales update with an earnings warning on Thursday. The reason for the decreased first-quarter expectations is also the reason for this column: the weather.  |
The Motley Fool April 8, 2005 Rich Duprey |
More Is Better at A.C. Moore Arts and crafts retailer reports dip in comps, but predicts beating quarterly estimates.  |
The Motley Fool April 8, 2005 Rick Aristotle Munarriz |
Stock Madness 2005: Netflix vs. Sirius Two niche pioneers fight for the right to be crowned champion.  |
| <Older 6731-6740 Newer> Return to current articles. |